furosemid polpharma
zakłady farmaceutyczne polpharma s.a. - furozemidas - injekcinis tirpalas - 20 mg/2 ml - furosemide
hizentra
csl behring gmbh - žmogaus normalus imunoglobulinas (scig) - imunologinių trūkumų sindromai - imuninės serumai ir imunoglobulinai, - replacement therapy in adults, children and adolescents (0-18 years) in:- primary immunodeficiency syndromes with impaired antibody production (see section 4. - secondary immunodeficiencies (sid) in patients who suffer from severe or recurrent infections, ineffective antimicrobial treatment and either proven specific antibody failure (psaf)* or serum igg level of.
libtayo
regeneron ireland designated activity company (dac) - cemiplimab - karcinoma, plazminė ląstelė - antinavikiniai vaistai - cutaneous squamous cell carcinomalibtayo as monotherapy is indicated for the treatment of adult patients with metastatic or locally advanced cutaneous squamous cell carcinoma (mcscc or lacscc) who are not candidates for curative surgery or curative radiation. basal cell carcinomalibtayo as monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic basal cell carcinoma (labcc or mbcc) who have progressed on or are intolerant to a hedgehog pathway inhibitor (hhi). non-small cell lung cancerlibtayo as monotherapy is indicated for the first-line treatment of adult patients with non-small cell lung cancer (nsclc) expressing pd-l1 (in ≥ 50% tumour cells), with no egfr, alk or ros1 aberrations, who have:locally advanced nsclc who are not candidates for definitive chemoradiation, ormetastatic nsclc. libtayo in combination with platinum‐based chemotherapy is indicated for the first‐line treatment of adult patients with nsclc expressing pd-l1 (in ≥ 1% of tumour cells), with no egfr, alk or ros1 aberrations, who have:locally advanced nsclc who are not candidates for definitive chemoradiation, ormetastatic nsclc. cervical cancerlibtayo as monotherapy is indicated for the treatment of adult patients with recurrent or metastatic cervical cancer and disease progression on or after platinum-based chemotherapy.
tezspire
astrazeneca ab - tezepelumab - astma - vaistai nuo obstrukcinių kvėpavimo takų ligų, - tezspire is indicated as an add-on maintenance treatment in adults and adolescents 12 years and older with severe asthma who are inadequately controlled despite high dose inhaled corticosteroids plus another medicinal product for maintenance treatment.
fortacin
recordati ireland ltd. - lidokainas, prilocaine - seksualinė disfunkcija, fiziologinė - anestezijos - suaugusių vyrų pirminės priešlaikinės ejakuliacijos gydymas.
berlocid
berlin-chemie ag (menarini group) - sulfametoksazolas/trimetoprimas - tabletės - 800 mg/160 mg - sulfamethoxazole and trimethoprim
ultrapen la 300 mg/ml, injekcinė suspensija
norbrook laboratories (ireland) limited. (airija) - injekcinė suspensija - 1 ml yra: benzilpenicilino prokaino - 300 mg. - galvijams ir kiaulėms, sergančioms infekcinėmis ligomis, kurių sukėlėjai jautrūs penicilinui, gydyti.
lysthenon
takeda austria gmbh - suksametonio chloridas - injekcinis tirpalas - 20 mg/ml - suxamethonium
argosulfan
bausch + lomb ireland limited - sulfatiazolo sidabro druska - kremas - 20 mg/g - sulfathiazole
lysthenon
lex ano, uab - suksametonio chloridas - injekcinis tirpalas - 20 mg/ml - suxamethonium